Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTrustpilot Regulatory News (TRST)

Share Price Information for Trustpilot (TRST)

Share Price is delayed by 15 minutes
Get Live Data
254.00    4.20 (1.68%)
Bid:
256.20
Ask:
256.80
Spread: 0.60 (0.234%)
Market Cap: £982.28m
TRST Live PriceLast checked at - London Stock Exchange

Intraday Trustpilot Share Chart

Trading Statement

13 Jul 2023 07:00

RNS Number : 9142F
Trustpilot Group PLC
13 July 2023
Β 

Trustpilot Group plc

13 July 2023

Β 

Trading update for the half-year ended 30 June 2023

Β 

Group revenue increased 18% with H1 adj. EBITDA of approximately $3m - upgrading profitability guidance for FY23

Β 

Trustpilot Group plc ("Trustpilot"), a leading global review platform, provides an update on trading for the six months ended 30 June 2023 ("H1'23").

Β 

US$

H1'23

H1'22

YoY actual

%

YoY constant currency %

Total revenue

$85m

$73m

+15

+18

ARR1

$180m

$149m

+21

+17

Total bookings2

$98m

$87m

+13

+16

Β 

H1'23 financial highlights

Trustpilot expects to report Group revenue of $85m (H1'22: $73m), up 18%3 at constant currency, with adj. EBITDA of approximately $3m (H1'22: $(5.4)m). We expect total annual recurring revenue (ARR) of $180m (H1'22: $149m), up 17%, with total bookings up 16% to $98m (H1'22: $87m). The last twelve months ("LTM") net dollar retention rate was 99% in the period (H1'22: 100%).

Β 

Regionally, bookings growth was 15% in the UK and 21% in Europe & RoW, a resilient performance against a challenging macroeconomic backdrop. In North America, bookings increased 11%, with an acceleration in Q2 aided by an encouraging improvement in our US net dollar retention rate, and continuing benefits from our refreshed go-to-market strategy in the region.

Β 

Our balance sheet remains strong and our net cash balance increased to $83m at the end of H1, reflecting positive free cash flow in the period, compared to $73.5m on 31 December 2022.

Β 

Update on appointment of new Chief Executive Officer

We are pleased with the progress being made in the search for a new Chief Executive Officer and look forward to updating the market in due course.

Β 

Outlook

We reiterate our expectation for FY'23 of mid-teens cc revenue growth. Due to resilient trading combined with improved operational efficiency, we now expect like-for-like full-year adj. EBITDA4 above the top end of the range of market expectations5 (excluding the effects of IFRS 15 - see note 6 below).

Β 

Notice of half-year results

Trustpilot is scheduled to report interim results for the six months ended 30 June 2023 on Tuesday 19 September 2023. On that day, a webcast and conference call for analysts and investors will take place at 09:00 BST. For registration and access to the webcast please visit https://investors.trustpilot.com.

Β 

Β 

Enquiries

Trustpilot

Derek Brown, Head of Investor Relations

Peter Holten MΓΌhlmann, CEO

Hanno Damm, CFO

Β 

investor.relations@trustpilot.com

https://investors.trustpilot.com

Β 

Financial PR

Teneo

James Macey White

Ed Cropley

+44 20 7353 4200

Β 

About Trustpilot

Trustpilot was founded in 2007 with a vision to create an independent currency of trust. A digital platform that brings businesses and consumers together to foster trust and inspire collaboration. We are free to use, open to everybody and built on transparency.

Β 

Trustpilot hosts reviews to help consumers shop with confidence and deliver rich insights to help businesses improve the experience they offer. The more consumers use our platform and share their own opinions; the richer the insights we offer businesses; and the more opportunities they have to earn the trust of consumers, from all around the world.

Β 

Trustpilot has over 850 employees and is headquartered in Copenhagen, with operations in London, Edinburgh, New York, Denver, Melbourne, Berlin, Amsterdam, and Milan.

Β 

1 Annual Recurring Revenue = Monthly Recurring Revenue x 12

2 The annual contract value of contracts signed in a given period

3 All YoY growth rates are shown on a constant currency basis

4 Adjusted EBITDA is defined as earnings before interest, tax, depreciation and amortisation, adjusted to exclude share-based compensation and restructuring costs

5 The current analyst consensus range for adjusted EBITDA of $2.4m to 4.0m (with a mean of $2.9m), based on company-compiled consensus representing the aggregate forecasts of 8 analysts collated on 28 April 2023

6 As our business expands and becomes profitable, under IFRS 15 - "Revenue from Contracts with Customers" - the Group is required to assess the recoverability of the incremental costs of obtaining a contract. Incremental costs for the Group relate largely to sales commissions paid to employees on new business. The Group has performed an assessment of recoverability and where costs are recoverable the Group intends to capitalise these commissions in H1'23 and to amortise them over the customer's expected useful life.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTGZGMNZFFGFZG
Date   Source Headline
1st Jun 20267:26 amRNSTransaction in Own Shares
29th May 20261:53 pmRNSTotal Voting Rights
26th May 20267:34 amRNSTransaction in Own Shares
19th May 20264:41 pmRNSResult of AGM
19th May 20261:00 pmRNSCEO’s Comments at the 2026 Annual General Meeting
18th May 20267:00 amRNSTransaction in Own Shares
13th May 20269:34 amRNSHolding(s) in Company
12th May 20266:17 pmRNSHolding(s) in Company
11th May 20267:59 amRNSTransaction in Own Shares
6th May 20267:00 amRNSTrust Capital Markets Event
5th May 202611:17 amRNSTransaction in Own Shares
1st May 20265:01 pmRNSHolding(s) in Company
30th Apr 20262:03 pmRNSTotal Voting Rights
27th Apr 202611:47 amRNSTrustpilot to host Trust education event
27th Apr 20267:28 amRNSTransaction in Own Shares
24th Apr 202610:16 amRNSHolding(s) in Company
23rd Apr 20262:31 pmRNSDirector/PDMR Shareholding
22nd Apr 202611:07 amRNSDirector Declaration
21st Apr 20267:00 amRNSAppointment of Non-Executive Director
20th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20264:38 pmRNS2025 Annual Report and Notice of 2026 AGM
13th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20264:23 pmRNSDirector/PDMR Shareholding
7th Apr 20268:31 amRNSDirector/PDMR Shareholding
7th Apr 20268:14 amRNSTransaction in Own Shares
31st Mar 20264:56 pmRNSTotal Voting Rights
30th Mar 20268:27 amRNSTransaction in Own Shares
27th Mar 20264:13 pmRNSBlock Admission Application
26th Mar 20264:10 pmRNSDirector/PDMR Shareholding
25th Mar 20267:05 amRNSCompletion of share buyback programme
24th Mar 20263:54 pmRNSDirector/PDMR Shareholding
24th Mar 20263:45 pmRNSHolding(s) in Company
24th Mar 20267:00 amRNSAppointment of Marcus Roy as CFO
24th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNSResults of secondary placing in Trustpilot
23rd Mar 20262:03 pmRNSTrustpilot to appeal AGCM finding
20th Mar 202611:20 amRNSHolding(s) in Company
19th Mar 20263:19 pmRNSDirector/PDMR Shareholding
19th Mar 20262:59 pmRNSHolding(s) in Company
17th Mar 20267:00 amRNSShare Buyback Programme
17th Mar 20267:00 amRNSShare Buyback Programme
17th Mar 20267:00 amRNSProfitability ahead of expectations
17th Mar 20267:00 amRNSProfitability ahead of expectations
16th Mar 20263:09 pmRNSHolding(s) in Company
16th Mar 20263:09 pmRNSHolding(s) in Company
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.